American-Israeli Breakthrough in Bone Reconstruction

In recent years, orthopedics has experienced a true technological boom, with 3D printing technology being one of the main drivers of this process. In 2024–2025, the Hospital for Special Surgery (HSS) in New York, one of the leading orthopedic clinics in the US, in collaboration with the Israeli Ichilov Medical Center in Tel Aviv, is actively implementing 3D-printed implants for osteointegration. This innovation allows for the creation of customized structures that perfectly match the patient's anatomy, reduce surgery time, and accelerate recovery. The project combines American expertise in orthopedic surgery with Israeli experience in medical technologies, making it an example of effective international cooperation.

Personalized 3D Printing in Joint and Bone Surgery

Dr. Robert Rosenbruch from HSS and Dr. Amir Sternheim from Ichilov have become key figures in this initiative. Their goal is to overcome the limitations of standard implants, which require prolonged adaptation and can cause complications. "The use of 3D technologies allows us to achieve unprecedented accuracy in joint reconstruction," notes Dr. Sternheim. The technology is already being applied in complex cases, such as bone reconstruction after injuries or oncological surgeries.

A significant advantage is the ability for preoperative planning: surgeons can virtually model the surgery, determine the optimal position of the implant, and anticipate possible complications before the procedure begins. This enhances the safety of interventions and improves prognosis.

The process of creating 3D-printed implants begins with detailed scanning of the damaged area using CT or MRI. The obtained data is processed by specialized software that creates a digital model, which is then sent to a 3D printer. The printer uses biocompatible materials, such as titanium alloys or polymers, allowing for the recreation of complex structures with a porous surface for better osteointegration.

Modern printers utilize selective laser sintering (SLS) or electron beam melting (EBM) technologies, creating a microporous structure with pores ranging from 100 to 500 microns—optimal for the growth of bone tissue and vessels. This precision ensures high biomechanical compatibility of the implant with the patient's bone.

In addition to individualized design, the technology reduces the duration of surgeries, as there is no need to fit the implant during the intervention. This lowers the risk of complications and promotes rapid recovery. Patients report less pain and a shorter hospitalization period—at Ichilov, the length of stay has decreased by 20–30%.

An additional advantage is the ability to combine materials with different properties. For example, the base may be made of titanium, while the surface is coated with a bioactive layer to enhance integration.

International Cooperation and a Look to the Future

The collaboration between HSS and Ichilov has been made possible by strong ties between medical centers in the US and Israel. Israeli companies, such as Nano Dimension, Stratasys, and CollPlant, provide technological support: from high-precision 3D printers to bioactive materials. CollPlant stands out for developing a technology for producing human collagen using genetically modified plants.

The American side contributes clinical expertise and access to large research databases. HSS performs over 30,000 surgeries annually, providing ideal conditions for testing and implementing new solutions. Regular exchanges of specialists and joint master classes accelerate the introduction of innovations and foster mutual learning.

As part of the partnership, a common database of clinical data is being formed, allowing for the analysis of the effectiveness of various types of implants and materials. This contributes to the continuous improvement of technologies and the updating of treatment standards.

The future of 3D printing in orthopedics looks promising. It is expected that in the coming years, it will become the standard in reconstructive surgery, especially in complex cases following injuries and oncological interventions. Developments are underway for biodegradable implants that will eventually be completely replaced by bone tissue.

Promising directions include 4D printing, where structures can change properties under the influence of external factors, and integration with sensors that monitor healing in real-time. The use of artificial intelligence for designing truly personalized solutions based on data analysis is also being developed.

Despite the need to comply with strict regulatory requirements and establish new quality standards, the advantages of the technology are clear: less trauma, rapid recovery, and a high level of implant adaptation. Thanks to such large-scale international projects, orthopedics is moving towards a new era of personalized medicine.